Fennemore, a healthcare attorney with Fennemore who advises medical practices, health care entities, and health care professionals on health ...
Nearly two-thirds of children that were found to have early-stage type 1 diabetes through a screening program in eight European countries had no parent or sibling with the disease ...
Bispecific antibodies and CAR-T therapies are changing cancer treatment, and community oncology practices need to be ready to deliver them, according to Melody Chang, R.Ph., BCOP, MBA, vice president ...
Adults with type 2 diabetes who don't use insulin lowered their A1C by 0.9 percentage points more with a continuous glucose monitor (CGM) than with routine care over 26 weeks, according to results ...
Luis Garza, M.D., Ph.D., is a professor of dermatology at Johns Hopkins University School of Medicine in Baltimore and an expert on hidradenitis suppurativa (HS), a chronic skin condition ...
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility. A North Carolina outsourcing facility is pulling 22 vials of ...
Roughly 10% of patients diagnosed with lung cancer today are younger than 50, according to Eric K. Singhi, M.D., of the ...
Hospital readmission is a common occurrence for patients with chronic obstructive pulmonary disorder (COPD) that patients and ...
Rex Hoffman, M.D., MBA, of Providence Holy Cross walks through a CMO’s day in a hospital that often runs 85% to 100% full, ...
Caregivers of children with ADHD and sleep problems tend to place more weight on improving daytime ADHD symptoms than on ...
Older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who started a GLP-1 receptor agonist had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results